Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.

New York-based Metsera, a biopharma developing medicines for obesity and metabolic diseases, has closed a $215 million Series ...

The sizeable new round follows the announcement of phase 1 data for its lead asset MET-097i in September, and according to ...

Orderful has raised $15 million with NewRoad Capital Partners to help expand Orderful’s offerings, including self-service EDI ...

Despite crowding in the next-gen weight loss space, Metsera has raised over $500 million since its April launch, indicating a ...

HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and nine months ended September 30, 2024. The Company reported net sales for ...

Bellevue Capital Partners, one of the largest shareholders of Global Net Lease, Inc. (NYSE: GNL), announces the acquisition of an additional 100,000 shares of GNL. This strategic investment ...

The alchemy of the venture capital process, in which investments are catalyzed over a number of years into a successful IPO ...

There is also an oral GLP-1 RA peptide called MET-002, a product of Metsera’s platform for optimizing the oral delivery of ...

Stock analysts at Alliance Global Partners cut their FY2024 earnings estimates for shares of Verano in a research note issued to investors on Thursday, November 7th. Alliance Global Partners analyst A ...

Lifecore now operates at less than 35% utilization, meaning that it can almost triple revenue with virtually no additional ...

CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology ...